Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Habig Scott Michael. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 5 filings have been published. Split: 1 buy · 2 sells. Total volume traded: €205k. Activity tracked since 9 November 2022. The latest transaction was disclosed on 6 August 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Habig Scott Michael is a declarant linked to Aurinia Pharmaceuticals Inc., where he is Chief Commercial Officer. The record shows 5 filings in total, and among the 5 sampled filings, buys amount to EUR 24874 and sells to EUR 180389, between 2022-11-14 and 2024-08-08, with the dominant transaction nature listed as sale.